Determine the safety and tolerability of VRx-3996/valganciclovir. Evaluate the impact of parameters of HIV infection (e.g., CD4 cell counts, HIVqPCR) on safety and efficacy. And Evaluate the impact of VRx-3996/valganciclovir on replication of non-Alpha herpesviruses.
Lone Tree Medical Center
University of Colorado Hospital
Brad Haverkos, MD
Protocol Number: 17-2074
More information available at ClinicalTrials.gov: NCT03397706
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers